The Impact of Pathologic Upgrading of Gleason Score 7 Prostate Cancer on the Risk of the Biochemical Recurrence after Radical Prostatectomy.
Juhyun ParkSangjun YooMin Chul ChoMin Hyun ChoChang Wook JeongJa Hyeon KuCheol KwakHyeon Hoe KimHyeon JeongPublished in: BioMed research international (2018)
The information on pathologic upgrading in the biopsy reports of patients could help to provide more detailed analysis for the biochemical recurrence of GS 7 prostate cancer.
Keyphrases
- prostate cancer
- radical prostatectomy
- end stage renal disease
- neoadjuvant chemotherapy
- ejection fraction
- newly diagnosed
- chronic kidney disease
- locally advanced
- peritoneal dialysis
- emergency department
- squamous cell carcinoma
- healthcare
- free survival
- radiation therapy
- rectal cancer
- health information
- lymph node
- adverse drug